pLenti PGK Blast V5-LUC (w528-1) Citations (9)

Originally described in: A versatile viral system for expression and depletion of proteins in mammalian cells.
Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529. PubMed Journal

---

Articles Citing pLenti PGK Blast V5-LUC (w528-1)

Articles
Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma. Gil del Alcazar CR, Hardebeck MC, Mukherjee B, Tomimatsu N, Gao X, Yan J, Xie XJ, Bachoo R, Li L, Habib AA, Burma S. Clin Cancer Res. 2014 Mar 1;20(5):1235-48. doi: 10.1158/1078-0432.CCR-13-1607. Epub 2013 Dec 23. PubMed
Talin1 phosphorylation activates beta1 integrins: a novel mechanism to promote prostate cancer bone metastasis. Jin JK, Tien PC, Cheng CJ, Song JH, Huang C, Lin SH, Gallick GE. Oncogene. 2015 Apr 2;34(14):1811-21. doi: 10.1038/onc.2014.116. Epub 2014 May 5. PubMed
O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells. Donovan K, Alekseev O, Qi X, Cho W, Azizkhan-Clifford J. Invest Ophthalmol Vis Sci. 2014 Oct 28;55(12):7862-73. doi: 10.1167/iovs.14-14048. PubMed
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, Lucia MS, Wu M, Shi L, Cimic A, Sirintrapun SJ, Nolley R, Pac C, Chen H, Peehl DM, Xu J, Liu W, Costello JC, Cramer SD. Cancer Res. 2015 Mar 15;75(6):1021-34. doi: 10.1158/0008-5472.CAN-14-1596. PubMed
Increased type III TGF-beta receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition. Huang JJ, Corona AL, Dunn BP, Cai EM, Prakken JN, Blobe GC. Oncogene. 2019 May;38(18):3402-3414. doi: 10.1038/s41388-018-0672-7. Epub 2019 Jan 14. PubMed
Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells. Tai HC, Lee TH, Tang CH, Chen LP, Chen WC, Lee MS, Chen PC, Lin CY, Chi CW, Chen YJ, Lai CT, Chen SS, Liao KW, Lee CH, Wang SW. Mar Drugs. 2019 Apr 6;17(4). pii: md17040215. doi: 10.3390/md17040215. PubMed
The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma. Roh V, Hiou-Feige A, Misetic V, Rivals JP, Sponarova J, Teh MT, Ferreira Lopes S, Truan Z, Mermod M, Monnier Y, Hess J, Tolstonog GV, Simon C. J Pathol. 2020 Jan;250(1):107-119. doi: 10.1002/path.5342. Epub 2019 Dec 3. PubMed
VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models. Allen V, Coulombe J, Zhao H, Kreps LM, Cook DP, Pryce B, Clemons M, Vanderhyden BC, Gray DA, Addison CL. Br J Cancer. 2022 Jul;127(1):56-68. doi: 10.1038/s41416-022-01778-7. Epub 2022 Mar 22. PubMed
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. Monteiro C, Miarka L, Perea-Garcia M, Priego N, Garcia-Gomez P, Alvaro-Espinosa L, de Pablos-Aragoneses A, Yebra N, Retana D, Baena P, Fustero-Torre C, Grana-Castro O, Troule K, Caleiras E, Tezanos P, Muela P, Cintado E, Trejo JL, Sepulveda JM, Gonzalez-Leon P, Jimenez-Roldan L, Moreno LM, Esteban O, Perez-Nunez A, Hernandez-Lain A, Mazarico Gallego J, Ferrer I, Suarez R, Garrido-Martin EM, Paz-Ares L, Dalmasso C, Cohen-Jonathan Moyal E, Siegfried A, Hegarty A, Keelan S, Vareslija D, Young LS, Mohme M, Goy Y, Wikman H, Fernandez-Alen J, Blasco G, Alcazar L, Cabanuz C, Grivennikov SI, Ianus A, Shemesh N, Faria CC, Lee R, Lorigan P, Le Rhun E, Weller M, Soffietti R, Bertero L, Ricardi U, Bosch-Barrera J, Sais E, Teixidor E, Hernandez-Martinez A, Calvo A, Aristu J, Martin SM, Gonzalez A, Adler O, Erez N, Valiente M. Nat Med. 2022 Apr;28(4):752-765. doi: 10.1038/s41591-022-01749-8. Epub 2022 Apr 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.